OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

3 Projects | 1 Researchers | $158,980 Invested

2022

Clinical Trials for Alzheimer's Disease Congress

Nathanaelle Touchon

Clinical Trials for Alzheimer’s Disease CTAD

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed

2021

Clinical Trials for Alzheimer's Disease Congress

Nathanaelle Touchon

Clinical Trials for Alzheimer’s Disease CTAD

  • Funding Amount: $48,480
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed

2020

Clinical Trials for Alzheimer's Disease Congress

Nathanaelle Touchon

Clinical Trials for Alzheimer's Disease (CTAD) Digital Conference

  • Funding Amount: $10,500
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed